Back to mobile site

SciClone Pharma (SCLN) Names Nancy Chang as Director

September 23, 2013 6:29 AM EDT Send to a Friend
SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN) today announced that Nancy T. Chang, Ph.D., has been appointed a member of the Company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login